Luo, Wen
Hoang, Hai
Miller, Katherine E.
Zhu, Hongwen
Xu, Serena
Mo, Xiaokui
Garfinkle, Elizabeth A. R.
Costello, Heather
Wijeratne, Saranga
Chemnitz, Wiebke
Gandhi, Ronan
Liao, Yanling
Ayello, Janet
Gardenswartz, Aliza
Rosenblum, Jeremy M.
Cassady, Kevin A.
Mardis, Elaine R.
Lee, Dean A.
Cripe, Timothy P.
Cairo, Mitchell S.
Article History
Received: 27 April 2024
Accepted: 6 June 2024
First Online: 11 July 2024
Declarations
:
: All animal studies were performed in accordance with protocols approved by the New York Medical College Institutional Animal Care and Use Committee.
: Not applicable.
: MSC has served as a consultant for Jazz Pharmaceuticals, Omeros Pharmaceuticals and Abbvie; Speakers Bureau for Jazz Pharmaceuticals and Sobi; and research funding from Merck, Miltenyi Biotec, Servier, Omeros, Jazz and Janssen. DAL reports personal fees and other from Kiadis Pharma, CytoSen Therapeutics, Courier Therapeutics, and Caribou Biosciences outside the submitted work. In addition, DAL has a patent broadly related to NK cell therapy of cancer with royalties paid to Kiadis Pharma. TPC recently served as a one-time consultant to Blueprint, Incyte, Oncopeptides, DSMB chair for SpringWorks and is a cofounder of Vironexis Biotherapeutics, Inc. Other co-authors declare they have no conflict of interest.